Monobenzone topical (for the skin) is used to permanently lighten skin in people with vitiligo. Depigmenting darker skin around the areas of vitiligo helps even out coloring and appearance of the skin.

MBEH or monobenzone is the most commonly used depigmenting agent used in vitiligo. It is the only depigmentation treatment for extensive vitiligo that has been approved by the FDA (Food and Drug Agency, United States of America).

Step into the world of skin confidence with Benoquin® Monobenzone Cream 20%. This cream is a game-changer for individuals battling vitiligo. Here’s why: Employs the potency of Monobenzone 20% to restore a more uniform skin appearance; Witness remarkable results over time by viewing before and after pictures

USES: Monobenzone is used to treat the uneven appearance of the skin due to a loss of skin color (vitiligo). It works by permanently removing color from normal skin located around skin with vitiligo.

Benoquin is applied two to three times daily as a treatment for vitiligo. 1 Depigmentation may begin in one to four months. However, complete depigmentation can take up to four years. 1,2 Prescribing information states that treatment should be discontinued if desired results are not achieved after four months of use. References.

While there is no cure, there are several treatment options, notably depigmentation in severe cases. Monobenzone is the most potent depigmenting agent. However, its use is limited due to the permanent and potent nature of the drug.

Apr 21, 2024 · Monobenzone is a monobenzyl ether of hydroquinone and is known for its depigmenting properties. When applied to the skin, Benoquin Cream acts by reducing or inhibiting the production of melanin, resulting in skin lightening or depigmentation.

Jan 7, 2024 · Benoquin Cream is especially effective in treating vitiligo. Monobenzone, which is its active ingredient, works as a depigmenting agent. Benoquin aims to provide a lighter skin tone by decreasing pigmentation in the surrounding areas of vitiligo spots.

Jul 6, 2018 · Monobenzone or monobenzyl ether of hydroquinone (MBEH) is a drug approved by the FDA for final depigmentation of the skin in patients with advanced vitiligo (vitiligo universalis). It is prepared as a 20-40% topical formulation such as a cream or ointment and is applied twice a day to affected areas.